CONMED (CNMD) Competitors

CONMED (NYSE:CNMD) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.

Does the media favor CNMD or STVN?

In the previous week, CONMED had 1 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for CONMED and 7 mentions for Stevanato Group. CONMED's average media sentiment score of 1.31 beat Stevanato Group's score of 1.14 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate CNMD or STVN?

CONMED presently has a consensus target price of $62.20, suggesting a potential upside of 6.38%. Given CONMED's higher probable upside, equities research analysts plainly believe CONMED is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Does the MarketBeat Community prefer CNMD or STVN?

CONMED received 6 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.27% of users gave Stevanato Group an outperform vote while only 45.68% of users gave CONMED an outperform vote.

Company	Underperform	Outperform
CONMED	Outperform Votes 37 45.68%	Underperform Votes 44 54.32%
Stevanato Group	Outperform Votes 31 63.27%	Underperform Votes 18 36.73%

Is CNMD or STVN a better dividend stock?

CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.4%. Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. CONMED pays out 21.1% of its earnings in the form of a dividend. Stevanato Group pays out 11.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has raised its dividend for 1 consecutive years.

Which has higher earnings and valuation, CNMD or STVN?

Stevanato Group has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.32B	1.37	$132.42M	$3.80	15.39
Stevanato Group	$1.12B	6.45	$157.62M	$0.51	46.98

Is CNMD or STVN more profitable?

Stevanato Group has a net margin of 10.47% compared to CONMED's net margin of 10.13%. CONMED's return on equity of 14.31% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	10.13%	14.31%	5.64%
Stevanato Group	10.47%	9.86%	5.79%

Which has more risk and volatility, CNMD or STVN?

CONMED has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.

Summary

Stevanato Group beats CONMED on 11 of the 20 factors compared between the two stocks.